| Literature DB >> 29284090 |
Kristoffer Peterson1, Rohit Kumar2, Olof Stenström3, Priya Verma1, Prashant R Verma1, Maria Håkansson4, Barbro Kahl-Knutsson5, Fredrik Zetterberg6, Hakon Leffler5, Mikael Akke3, Derek T Logan2,4, Ulf J Nilsson1.
Abstract
Symmetrical and asymmetrical fluorinated phenyltriazolyl-thiodigalactoside derivatives have been synthesized and evaluated as inhibitors of galectin-1 and galectin-3. Systematic tuning of the phenyltriazolyl-thiodigalactosides' fluoro-interactions with galectin-3 led to the discovery of inhibitors with exceptional affinities (Kd down to 1-2 nM) in symmetrically substituted thiodigalactosides as well as unsurpassed combination of high affinity (Kd 7.5 nM) and selectivity (46-fold) over galectin-1 for asymmetrical thiodigalactosides by carrying one trifluorphenyltriazole and one coumaryl moiety. Studies of the inhibitor-galectin complexes with isothermal titration calorimetry and X-ray crystallography revealed the importance of fluoro-amide interaction for affinity and for selectivity. Finally, the high affinity of the discovered inhibitors required two competitive titration assay tools to be developed: a new high affinity fluorescent probe for competitive fluorescent polarization and a competitive ligand optimal for analyzing high affinity galectin-3 inhibitors with competitive isothermal titration calorimetry.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29284090 DOI: 10.1021/acs.jmedchem.7b01626
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446